Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-Frequency Neuronavigated rTMS in Auditory Verbal Hallucinations: A Pilot Double-Blind Controlled Study in Patients With Schizophrenia.
Dollfus S, Jaafari N, Guillin O, Trojak B, Plaze M, Saba G, Nauczyciel C, Montagne Larmurier A, Chastan N, Meille V, Krebs MO, Ayache SS, Lefaucheur JP, Razafimandimby A, Leroux E, Morello R, Marie Batail J, Brazo P, Lafay N, Wassouf I, Harika-Germaneau G, Guillevin R, Guillevin C, Gerardin E, Rotharmel M, Crépon B, Gaillard R, Delmas C, Fouldrin G, Laurent G, Nathou C, Etard O. Dollfus S, et al. Among authors: guillin o. Schizophr Bull. 2018 Apr 6;44(3):505-514. doi: 10.1093/schbul/sbx127. Schizophr Bull. 2018. PMID: 29897597 Free PMC article. Clinical Trial.
The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study.
Rothärmel M, Quesada P, Husson T, Harika-Germaneau G, Nathou C, Guehl J, Dalmont M, Opolczynski G, Miréa-Grivel I, Millet B, Gérardin E, Compère V, Dollfus S, Jaafari N, Bénichou J, Thill C, Guillin O, Moulier V. Rothärmel M, et al. Among authors: guillin o. Psychol Med. 2023 Apr;53(5):2060-2071. doi: 10.1017/S0033291721003810. Epub 2021 Sep 28. Psychol Med. 2023. PMID: 34579796 Clinical Trial.
Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification.
Nicolas G, Pottier C, Charbonnier C, Guyant-Maréchal L, Le Ber I, Pariente J, Labauge P, Ayrignac X, Defebvre L, Maltête D, Martinaud O, Lefaucheur R, Guillin O, Wallon D, Chaumette B, Rondepierre P, Derache N, Fromager G, Schaeffer S, Krystkowiak P, Verny C, Jurici S, Sauvée M, Vérin M, Lebouvier T, Rouaud O, Thauvin-Robinet C, Rousseau S, Rovelet-Lecrux A, Frebourg T, Campion D, Hannequin D; French IBGC Study Group. Nicolas G, et al. Among authors: guillin o. Brain. 2013 Nov;136(Pt 11):3395-407. doi: 10.1093/brain/awt255. Epub 2013 Sep 24. Brain. 2013. PMID: 24065723
A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).
Moulier V, Krir MW, Dalmont M; SURECT Group; Guillin O, Rothärmel M. Moulier V, et al. Among authors: guillin o. Trials. 2021 Apr 15;22(1):284. doi: 10.1186/s13063-021-05227-3. Trials. 2021. PMID: 33858488 Free PMC article.
Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study.
Bouaziz N, Laidi C, Bulteau S, Berjamin C, Thomas F, Moulier V, Benadhira R, Szekely D, Poulet E, Galvao F, Guillin O, Castillo MC, Sauvaget A, Plaze M, Januel D, Brunelin J, Rotharmel M. Bouaziz N, et al. Among authors: guillin o. J Affect Disord. 2023 Apr 1;326:26-35. doi: 10.1016/j.jad.2023.01.070. Epub 2023 Jan 25. J Affect Disord. 2023. PMID: 36708953
Efficacy and Safety of Transcranial Electric Stimulation during the Perinatal Period: A Systematic Literature Review and Three Case Reports.
Laurin A, Nard N, Dalmont M, Bulteau S, Bénard C, Bonnot O, Winer N, Dupont F, Apter G, Terranova-Commessie F, Guillin O, El-Hage W, Sauvaget A, Rothärmel M. Laurin A, et al. Among authors: guillin o. J Clin Med. 2022 Jul 13;11(14):4048. doi: 10.3390/jcm11144048. J Clin Med. 2022. PMID: 35887812 Free PMC article. Review.
Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study.
Rothärmel M, Benosman C, El-Hage W, Berjamin C, Ribayrol D, Guillin O, Gaillard R, Berkovitch L, Moulier V. Rothärmel M, et al. Among authors: guillin o. Front Psychiatry. 2022 Jul 8;13:865466. doi: 10.3389/fpsyt.2022.865466. eCollection 2022. Front Psychiatry. 2022. PMID: 35873243 Free PMC article.
87 results